batiraxcept
Showing 1 - 4 of 4
Recurrent High Grade Uterine Cancer Trial in United States (Paclitaxel, Batiraxcept)
Not yet recruiting
- Recurrent High Grade Uterine Cancer
- Paclitaxel
- Batiraxcept
-
San Francisco, California
- +3 more
Apr 11, 2023
Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- Batiraxcept
- +2 more
-
Baltimore, Maryland
- +16 more
Jan 17, 2023
Pancreatic Adenocarcinoma Trial in United States (batiraxcept, Nab paclitaxel, Gemcitabine)
Recruiting
- Pancreatic Adenocarcinoma
- batiraxcept
- +2 more
-
Santa Monica, California
- +16 more
Feb 21, 2022
Platinum-resistant Ovarian Cancer Trial in Worldwide (Batiraxcept, Paclitaxel, Placebo)
Recruiting
- Platinum-resistant Ovarian Cancer
- Batiraxcept
- +2 more
-
Mobile, Alabama
- +149 more
Dec 9, 2022